We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Circassia Group Plc | LSE:CIR | London | Ordinary Share | GB00BJVD3B28 | ORD 0.08P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 34.00 | 33.10 | 34.90 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
02/12/2019 08:25 | And (for me) more importantly - still the 30m buyer to be revealed. Not even seen any rumours of who it is. | spectoacc | |
02/12/2019 08:08 | Hoping for a good week here can’t be much stock swapping left to do. Come on lady CIrc up to 1st r3sistance 28p | linton5 | |
30/11/2019 11:41 | From LSE: From the half year report;Cash balance of £19.8 million at 31 August 2019 (£21.0 million at 30 June 2019)· Net cash outflow expected to dramatically reduce during H2 2019 compared to H1 2019· Key revenue drivers in place (NIOX® direct sales in China; Duaklir® launch imminent; Tudorza® full control; LungFit PH3 (previously AirNOvent) launch planning)· Full year 2019 revenue expectation £60 million - £65 million· Focus on cost control to achieve positive EBITDA on approximately £75 million net annual sales--------------F | costax1654x | |
29/11/2019 15:38 | Charts are, of course, a nonsense, as all the many multi-billionaire TA'ers attest. But I do think CIR's going up, with so many sellers absorbed. | spectoacc | |
29/11/2019 15:23 | Is literally just about to break 22,will fly straight to 27 on a few buys!(27 is the next target),on charts | costax1654x | |
29/11/2019 14:41 | Off to the races if it can break through 22p... | 74tom | |
29/11/2019 10:48 | Interesting point the abbot, that could well be them and concur with the view that they are taking complete advantage of snapping up shares on the cheap...still want to now who bought the 30 million shares. | pre | |
29/11/2019 10:39 | 342k buyer also appears...someone accumulating and buying up stock aggressively. Every broker target is way above current share price...shows this has significant upside potential imv. | pre | |
29/11/2019 10:03 | Mega buy again | costax1654x | |
29/11/2019 09:19 | Ant ,a very popular chartist posted on Twitter,is followed by many so expecting a flurry of buys today | costax1654x | |
29/11/2019 09:18 | 27 next target on charts | costax1654x | |
29/11/2019 09:17 | Broker targets from 60-100 p | costax1654x | |
29/11/2019 09:17 | Institutional buys again today on duty | costax1654x | |
29/11/2019 08:48 | 100k buyer again.... | pre | |
29/11/2019 08:34 | CIR's Duaklir is a COPD drug which won approval for from the US FDA this year. Duaklir is a fixed-dose combination treatment of the long-acting muscarinic antagonist (LAMA) aclidinium bromide and long-acting beta-agonist (LABA) formoterol fumarate. The market is huge for this and is likely to grow with the levels of air pollution etc. | pre | |
29/11/2019 08:27 | Have they anything in the pipeline for approval? With all this air pollution looks like there will be an epidemic of asthma, COPD and lung problems so their products will be in demand! | r9505571 | |
29/11/2019 08:25 | 21.70 - 22.00 (GBX) at 08:25:00 on Market (LSE) | neilyb675 | |
29/11/2019 08:10 | For sure we will be into 30's by next Friday | costax1654x |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions